Pharmaceutical Giants and Startups Clash in Anxiety Treatment Market; Innovation vs. Generic Pressures Intensify
The anxiety disorder treatment market is a battleground of innovation and cost competition, pitting established pharmaceutical giants against agile startups. While legacy firms like Roche and Eli Lilly dominate with branded SSRIs, newer entrants are disrupting the sector with novel compounds, biosimilars, and digital tools. This clash is reshaping pricing, accessibility, and R&D priorities,...
0 Comentários 0 Compartilhamentos 20 Visualizações 0 Anterior